Lisata Therapeutics Inc.
3.72
0.08 (2.20%)
At close: Jan 15, 2025, 3:58 PM
3.72
0.05%
After-hours Jan 15, 2025, 03:59 PM EST

Lisata Therapeutics Statistics

Share Statistics

Lisata Therapeutics has 8.39M shares outstanding. The number of shares has increased by 1.05% in one year.

Shares Outstanding 8.39M
Shares Change (YoY) n/a
Shares Change (QoQ) 0.91%
Owned by Institutions (%) n/a
Shares Floating 6.92M
Failed to Deliver (FTD) Shares 614
FTD / Avg. Volume 2.23%

Short Selling Information

The latest short interest is 17.06K, so 0.2% of the outstanding shares have been sold short.

Short Interest 17.06K
Short % of Shares Out 0.2%
Short % of Float 0.25%
Short Ratio (days to cover) 1.79

Valuation Ratios

The PE ratio is -1.06 and the forward PE ratio is -1.15.

PE Ratio -1.06
Forward PE -1.15
PS Ratio 0
Forward PS null
PB Ratio 0.46
P/FCF Ratio -1.1
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

Currently the Enterprise Value (EV) is not available for Lisata Therapeutics Inc..

EV / Earnings n/a
EV / Sales n/a
EV / EBITDA n/a
EV / EBIT n/a
EV / FCF n/a

Financial Position

The company has a current ratio of 8.18, with a Debt / Equity ratio of 0.01.

Current Ratio 8.18
Quick Ratio 8.18
Debt / Equity 0.01
Total Debt / Capitalization 0.63
Cash Flow / Debt -65.68
Interest Coverage 0

Financial Efficiency

Return on equity (ROE) is -0.43% and return on capital (ROIC) is -47.97%.

Return on Equity (ROE) -0.43%
Return on Assets (ROA) -0.38%
Return on Capital (ROIC) -47.97%
Revenue Per Employee 0
Profits Per Employee -833.60K
Employee Count 25
Asset Turnover 0
Inventory Turnover 0

Taxes

Income Tax -2.33M
Effective Tax Rate 0.1

Stock Price Statistics

The stock price has increased by 26.53% in the last 52 weeks. The beta is 1.22, so Lisata Therapeutics 's price volatility has been higher than the market average.

Beta 1.22
52-Week Price Change 26.53%
50-Day Moving Average 2.98
200-Day Moving Average 3.05
Relative Strength Index (RSI) 66.59
Average Volume (20 Days) 27.50K

Income Statement

Revenue n/a
Gross Profit -189.00K
Operating Income -25.71M
Net Income -20.84M
EBITDA -25.52M
EBIT n/a
Earnings Per Share (EPS) -2.58
Full Income Statement

Balance Sheet

The company has 22.59M in cash and 305.00K in debt, giving a net cash position of 22.29M.

Cash & Cash Equivalents 22.59M
Total Debt 305.00K
Net Cash 22.29M
Retained Earnings -528.08M
Total Assets 38.20M
Working Capital 33.00M
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -20.03M and capital expenditures 0, giving a free cash flow of -20.03M.

Operating Cash Flow -20.03M
Capital Expenditures 0
Free Cash Flow -20.03M
FCF Per Share -2.48
Full Cash Flow Statement

Margins

Gross Margin n/a
Operating Margin n/a
Pretax Margin n/a
Profit Margin n/a
EBITDA Margin n/a
EBIT Margin n/a
FCF Margin n/a

Dividends & Yields

LSTA does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Payout Ratio n/a
Earnings Yield -69.35%
FCF Yield -64.18%
Dividend Details

Analyst Forecast

The average price target for LSTA is $15, which is 303.2% higher than the current price. The consensus rating is "Buy".

Price Target $15
Price Target Difference 303.2%
Analyst Consensus Buy
Analyst Count 1
Stock Forecasts

Stock Splits

The last stock split was on Sep 15, 2022. It was a backward split with a ratio of 1:15.

Last Split Date Sep 15, 2022
Split Type backward
Split Ratio 1:15

Scores

Altman Z-Score -17.06
Piotroski F-Score 1